Black Race, Male Sex Tied to Use of Pharmacological Restraint in Pediatric Emergency Visits

THURSDAY, Dec. 22, 2022 (HealthDay News) -- In mental and behavioral health (MBH) emergency department visits for children, higher rates of pharmacologic restraint are associated with male sex, Black race, timing of visits, and revisits, according to a study published online Dec. 19 in Pediatrics.
Ashley A. Foster, M.D., from the University of California in San Francisco, and colleagues used emergency department visit data identified from the Pediatric Health Information System (2010 to 2020) to identify 545,800 visits by children (aged 3 to 21 years) with a primary MBH diagnosis. The association between patient- and hospital-level factors and pharmacologic restraint use was examined.
The researchers found that 4.1 percent of visits involved pharmacologic restraint use. Restraint was associated with visits by children aged 18 to 21 years (odds ratio, 1.88), male sex (odds ratio, 1.25), Black race (odds ratio, 1.22), visits starting overnight (odds ratio, 1.68), visits starting on a weekend (odds ratio, 1.26), and repeat emergency department visits (odds ratio, 1.31). While every 100-visit increase in average annual MBH volume was associated with a 0.09 percent decrease in restraint use, there was no significant association between average annual emergency department volume and restraint use.
"In mental and behavioral health emergency visits for children, male sex, Black race, timing of visits, and revisits were associated with pharmacologic restraint," the authors write. "These findings have implications for equitably managing agitation in youth in the pediatric emergency department."
Related Posts
¿Busca el amor este San Valentín? Deslizar tanto el dedo quizá no ayude
LUNES, 13 de febrero de 2023 (HealthDay News) -- Si usted es una de los millones...
Many Smokers Who Want to Quit Just End Up Vaping, Too
WEDNESDAY, July 27, 2022 (HealthDay News) -- Many smokers eager to quit embrace...
Cessation Program in Cancer Clinics May Reach More Tobacco Smokers
FRIDAY, May 13, 2022 (HealthDay News) -- A low-burden point-of-care...
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
TUESDAY, Nov. 16, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that it...